⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Malathion lotion

مالاتیون لوسیون

⚠ Unverified

🪱 Antiparasitic Products, Insecticides And RepellentsPediculicide

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Use with caution 🇮🇷 Not found in Iran list ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA091559 ATC P03AX03

Market / country: 🇺🇸 USA

Ovide (US)

🧮 Dose calculator

Disease / regimen

Head lice · Regimen source: FDA Ovide · Dosage and Administration FDA Ovide · Pediatric Use

⛔ Not weight-dosed: apply to DRY hair just enough to wet hair and scalp thoroughly (especially back of head and neck), let dry naturally and leave uncovered; shampoo after 8–12 h and use a nit comb. If lice remain after 7–9 days, repeat once. FDA Ovide · Dosage and Administration FDA Ovide · Pediatric Use

🛡️ Safety & information

Contraindications

⛔ Neonates and infants — contraindicated (greater scalp absorption). FDA Ovide · Contraindications
⛔ Sensitivity to malathion or vehicle ingredients. FDA Ovide · Contraindications

Warnings

• Flammable: keep lotion and wet hair away from flames, hair dryers and electric curlers; do not smoke. FDA Ovide · Warnings

Formulations

Malathion 0.5% lotion (59 mL) — lotion 🇺🇸 USA FDA Ovide · How Supplied

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ovide · Pregnancy
“Pregnancy Category B There was no evidence of teratogenicity in studies in rats and rabbits at doses up to 900 mg/kg/day and 100 mg/kg/day malathion, respectively.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Ovide · Nursing Mothers
“Because many drugs are excreted in human milk, caution should be exercised when OVIDE Lotion is administered to (or handled by) a nursing mother.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ovide · Pediatric Use
“The safety and effectiveness of OVIDE Lotion in children less than 6 years of age has not been established via well-controlled trials.”
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA091559
DailyMed (FDA label)FDA Ovide
MedlinePlus (NIH)Malathion Topical
WHO ATC/DDDP03AX03
Darooyab (Iran)Malathion-Topical

🇮🇷 Not found in Iran list Darooyab · G-3138/Malathion-Topical

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Ovide · How Supplied FDA Ovide · Dosage and Administration FDA Ovide · Pediatric Use FDA Ovide · Contraindications FDA Ovide · Warnings FDA Ovide · Pregnancy FDA Ovide · Nursing Mothers FDA Ovide · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-3138/Malathion-Topical
Clinical review⚠ Unverified

🔗 Similar drugs

For the same diseases

Ivermectin 0.5% lotion Spinosad 0.9% suspension